Market Cap 144.87B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.90
Forward PE 8.53
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 34,190,100
Avg Vol 68,446,008
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 55%
Beta 0.47
Analysts Sell
Price Target $27.95

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Tiger65
Tiger65 Jan. 11 at 2:53 PM
$PFE The big picture
0 · Reply
Tiger65
Tiger65 Jan. 11 at 2:36 PM
$PFE one good thing about the constant pressure on the shareprice is that it forced management to do all they could to make their company return back on track. The correction from 62 to 21 was way overdone, because COVID income should be regarded as an extra income to an already profitable business. The mistake of announcing and lacking a GLP drug brought it further down but is gone now. That’s why it took so long to turn this thing around but the shareprice is still extremely cheap and will return to the mean. Last week has shown one thing: there is a fire looming and it might soon break out and turn into a flashover.
0 · Reply
A_Train1
A_Train1 Jan. 11 at 2:04 PM
$PFE Stock is in the penalty box for: - acquisitions that don’t produce (global blood therapeutics) - overpaying for acquisitions (SeaGen) - run of bad luck (fat drug failure) - getting schooled by Novo on the other dat drug acquisition - lame duck CEO - patent cliff risks - and COVID (being involved) - ANY THAT I’M MISSING?
0 · Reply
taxplanr
taxplanr Jan. 11 at 12:13 PM
$BNTX $MRNA $PFE efforts to suppress malignantRNA C19 cancer causing link is gaining more attention 🤣🤣🤣 https://www.dailymail.co.uk/sciencetech/article-15440249/cancer-Covid-vaccination-journal-cyberattack.html
0 · Reply
TheWinningStock
TheWinningStock Jan. 11 at 12:11 PM
$PFE ....🤑
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 11 at 4:53 AM
$PFE trading at $25 with volume 33% below average, while $ABBV sitting at $220 with 6% above average volume. ABBV showing strength with a higher price level and increased volume - seems like a solid Healthcare sector play! Will these trends continue in the sector?
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 11 at 2:03 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: FEB 06 2026 Buy in Price: $0.36 - $0.37 Sell Price: $0.63 Profit : +74% (Turn every $1 into $1.74) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
jdlman
jdlman Jan. 10 at 10:56 PM
$PFE can this news make some noise? This stock has been so disappointing
1 · Reply
TheWinningStock
TheWinningStock Jan. 10 at 3:48 PM
$PFE ......🤑 https://www.stocktitan.net/news/PFE/pfizer-s-braftovi-regimen-with-additional-chemotherapy-backbone-mdg449j40fxg.html
0 · Reply
DefenseMania
DefenseMania Jan. 10 at 3:01 PM
$PFE great news just out now , don’t have the. PR yet
0 · Reply
Latest News on PFE
Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 4 days ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK


Pfizer 2026: The Reset Year

Jan 2, 2026, 2:52 PM EST - 8 days ago

Pfizer 2026: The Reset Year


Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound

Dec 19, 2025, 11:45 AM EST - 22 days ago

Pfizer Isn't Dead Money, Pipeline Execution Can Spark A Rebound


Pfizer Stock Can Sink More. Here Is How

Dec 17, 2025, 2:36 PM EST - 24 days ago

Pfizer Stock Can Sink More. Here Is How


Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript

Dec 16, 2025, 2:39 PM EST - 25 days ago

Pfizer Inc. (PFE) Q4 2026 Guidance Call Transcript


Pfizer falls on disappointing guidance

Dec 16, 2025, 12:33 PM EST - 25 days ago

Pfizer falls on disappointing guidance


Here's why Pfizer is revising its revenue forecasts

Dec 16, 2025, 7:47 AM EST - 26 days ago

Here's why Pfizer is revising its revenue forecasts


Pfizer Declares First-Quarter 2026 Dividend

Dec 12, 2025, 12:00 PM EST - 4 weeks ago

Pfizer Declares First-Quarter 2026 Dividend


Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 5 weeks ago

Pfizer: The Market Is Still Wrong About It


Tiger65
Tiger65 Jan. 11 at 2:53 PM
$PFE The big picture
0 · Reply
Tiger65
Tiger65 Jan. 11 at 2:36 PM
$PFE one good thing about the constant pressure on the shareprice is that it forced management to do all they could to make their company return back on track. The correction from 62 to 21 was way overdone, because COVID income should be regarded as an extra income to an already profitable business. The mistake of announcing and lacking a GLP drug brought it further down but is gone now. That’s why it took so long to turn this thing around but the shareprice is still extremely cheap and will return to the mean. Last week has shown one thing: there is a fire looming and it might soon break out and turn into a flashover.
0 · Reply
A_Train1
A_Train1 Jan. 11 at 2:04 PM
$PFE Stock is in the penalty box for: - acquisitions that don’t produce (global blood therapeutics) - overpaying for acquisitions (SeaGen) - run of bad luck (fat drug failure) - getting schooled by Novo on the other dat drug acquisition - lame duck CEO - patent cliff risks - and COVID (being involved) - ANY THAT I’M MISSING?
0 · Reply
taxplanr
taxplanr Jan. 11 at 12:13 PM
$BNTX $MRNA $PFE efforts to suppress malignantRNA C19 cancer causing link is gaining more attention 🤣🤣🤣 https://www.dailymail.co.uk/sciencetech/article-15440249/cancer-Covid-vaccination-journal-cyberattack.html
0 · Reply
TheWinningStock
TheWinningStock Jan. 11 at 12:11 PM
$PFE ....🤑
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 11 at 4:53 AM
$PFE trading at $25 with volume 33% below average, while $ABBV sitting at $220 with 6% above average volume. ABBV showing strength with a higher price level and increased volume - seems like a solid Healthcare sector play! Will these trends continue in the sector?
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Jan. 11 at 2:03 AM
Enter: $PFE Calls Strike Price: $26 Expiry Date: FEB 06 2026 Buy in Price: $0.36 - $0.37 Sell Price: $0.63 Profit : +74% (Turn every $1 into $1.74) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us/
0 · Reply
jdlman
jdlman Jan. 10 at 10:56 PM
$PFE can this news make some noise? This stock has been so disappointing
1 · Reply
TheWinningStock
TheWinningStock Jan. 10 at 3:48 PM
$PFE ......🤑 https://www.stocktitan.net/news/PFE/pfizer-s-braftovi-regimen-with-additional-chemotherapy-backbone-mdg449j40fxg.html
0 · Reply
DefenseMania
DefenseMania Jan. 10 at 3:01 PM
$PFE great news just out now , don’t have the. PR yet
0 · Reply
framus_morrigan
framus_morrigan Jan. 10 at 10:48 AM
$PFE Weekly chart. That pattern is running out of room, just saying ...
0 · Reply
taxplanr
taxplanr Jan. 10 at 12:43 AM
Stage 4 breast cancer results using Ivermectin and red light therapy $BNTX $MRNA $PFE https://www.tiktok.com/t/ZThF5pvTM/
0 · Reply
Willieberich
Willieberich Jan. 9 at 11:46 PM
$PFE if you are paid by some hedge funds to post here .to suppress and keep this dow .I personally would fire you ...I'll buy any dip here !
0 · Reply
Willieberich
Willieberich Jan. 9 at 11:42 PM
$PFE all of the negative people here .got nothing done to bring it down . I know your game .I've beat you in the past and I will do it again here !! I know 1 person on here has seen this on here .I onto have time time to sit here all day and post .I just buy ..........good luck people!!
0 · Reply
BananaSmoke
BananaSmoke Jan. 9 at 11:31 PM
$PFE what a turd
2 · Reply
DragonAlgo
DragonAlgo Jan. 9 at 11:24 PM
🐉 $PFE CALL — DragonAlgo® VIP Signal Contract: PFE 2026-01-16 C26 Expiry: 2026-01-16 | Strike: 25.50 | Type: CALL Option Plan (premium): Entry: 0.33 Stop: 0.24 TP1: 0.44 TP2: 0.57 TP3: 0.80 TA: Educational only — not financial advice. 🔗 https://dragonalgo.com
0 · Reply
MF__DOOM
MF__DOOM Jan. 9 at 10:43 PM
$QURE support needs to be retaken at $27 this was very predictable price action the good news is check my previous post date of 11/5/25 and you’ll see we have been consolidating for more than a month now right below $27 so it’s gonna be very shortly that we break above $30-40 RANGE and it will be quick when it breaks $80-100 is the target long term price (can come soon as eoy or 5 years out) and this price will easily come as well as for those who follow me or anybody here specifically with a history in Bio you’ll see every bio so far I’ve called out for a buyout has gotten it but also I say beware because a BO isn’t always good, as was the case with $BLUE, however I believe this will play out differently QURE already has a history with CSL Behring (not necessarily the bo buyer but CSL is my top guess followed by $BMY $PFE and $RHHBY last )
0 · Reply
venkyecom
venkyecom Jan. 9 at 10:23 PM
Paxlovid is currently not covered by any insurance , my friend has to pay 1400$ recently when he got covid 2 days back. $PFE
2 · Reply
hegdaom
hegdaom Jan. 9 at 9:39 PM
$CAPR Can anyone in two to three coherent sentences share here. Whats the argument for a short case? $PFE $LLY $MRK $BIIB $LLY
2 · Reply
Micheal_Pothead
Micheal_Pothead Jan. 9 at 9:00 PM
$PFE weird
0 · Reply
Tiger65
Tiger65 Jan. 9 at 8:36 PM
0 · Reply
Tiger65
Tiger65 Jan. 9 at 7:28 PM
$PFE still working on the two-year resistance levels. Would need some fresh impulse to constantly cross over. It eventually will.
0 · Reply